Why is Bloomage Biotechnology Corp. Ltd. ?
1
Poor Management Efficiency with a low ROCE of 13.76%
- The company has been able to generate a Return on Capital Employed (avg) of 13.76% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 5.37% and Operating profit at -23.35% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 10.21% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 5.37% and Operating profit at -23.35% over the last 5 years
4
With a fall in Net Sales of -21.64%, the company declared Very Negative results in Jun 26
- The company has declared negative results for the last 13 consecutive quarters
- INTEREST(HY) At CNY 3.29 MM has Grown at 66.77%
- NET SALES(Q) At CNY 926.77 MM has Fallen at -21.64%
- PRE-TAX PROFIT(Q) At CNY 55.76 MM has Fallen at -56.57%
5
With ROE of 3.38%, it has a attractive valuation with a 2.29 Price to Book Value
- Over the past year, while the stock has generated a return of -36.86%, its profits have risen by 143.6%
- At the current price, the company has a high dividend yield of 0.3
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bloomage Biotechnology Corp. Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Bloomage Biotechnology Corp. Ltd.
-34.84%
-1.19
31.74%
China Shanghai Composite
3.0%
0.22
14.72%
Quality key factors
Factor
Value
Sales Growth (5y)
5.37%
EBIT Growth (5y)
-23.35%
EBIT to Interest (avg)
70.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.72
Tax Ratio
4.73%
Dividend Payout Ratio
31.12%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.84%
ROE (avg)
10.21%
Valuation Key Factors 
Factor
Value
P/E Ratio
68
Industry P/E
Price to Book Value
2.29
EV to EBIT
79.50
EV to EBITDA
31.79
EV to Capital Employed
2.44
EV to Sales
3.95
PEG Ratio
NA
Dividend Yield
0.32%
ROCE (Latest)
3.06%
ROE (Latest)
3.38%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 934.35 MM
NET PROFIT(9M)
Higher at CNY 175.93 MM
-27What is not working for the Company
INTEREST(HY)
At CNY 3.29 MM has Grown at 66.77%
NET SALES(Q)
At CNY 926.77 MM has Fallen at -21.64%
PRE-TAX PROFIT(Q)
At CNY 55.76 MM has Fallen at -56.57%
RAW MATERIAL COST(Y)
Grown by 6.05% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.83 times
NET PROFIT(Q)
Fallen at -28.21%
Here's what is working for Bloomage Biotechnology Corp. Ltd.
Operating Cash Flow
Highest at CNY 934.35 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Here's what is not working for Bloomage Biotechnology Corp. Ltd.
Interest
At CNY 3.29 MM has Grown at 66.77%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 926.77 MM has Fallen at -21.64%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 55.76 MM has Fallen at -56.57%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
Fallen at -28.21%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Debtors Turnover Ratio
Lowest at 5.83 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 6.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading






